EUVIMEDEUVIMED entdecken
Crossref

Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α) ‐induced differentiation therapy for hepatocellular carcinoma

Fang Liu, Yu Peng, Hui Qian, Meng Chao Xiao, Chen Hong Ding, Xin Zhang, Wei Fen Xie iD

Journal of Digestive Diseases · 2024

DOI: 10.1111/1751-2980.13272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2024. Verfasst von Fang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Carcinoma, Hepatocellular, Liver Neoplasms, Cell Differentiation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In this study we aimed to assess the impact of acetylation of hepatocyte nuclear factor 4α (HNF4α) on lysine 458 on the differentiation therapy of hepatocellular carcinoma (HCC).

Methods

Periodic acid‐Schiff (PAS) staining, Dil‐acetylated low‐density lipoprotein (Dil‐Ac‐LDL) uptake, and senescence‐associated β‐galactosidase (SA‐β‐gal) activity analysis were performed to assess the differentiation of HCC cells. HNF4α protein was detected by western blot and immunohistochemistry (IHC). The effects of HNF4α‐K458 acetylation on HCC malignancy were evaluated in HCC cell lines, a Huh‐7 xenograft mouse model, and an orthotopic model. The differential expression genes in Huh‐7 xenograft tumors were screened by RNA‐sequencing analysis.

Results

K458R significantly enhanced the inhibitory effect of HNF4α on the malignancy of HCC cells, whereas K458Q reduced the inhibitory effects of HNF4α. Moreover, K458R promoted, while K458Q decreased, HNF4α‐induced HCC cell differentiation. K458R stabilized HNF4α, while K458Q accelerated the degradation of HNF4α via the ubiquitin proteasome system. K458R also enhanced the ability of HNF4α to inhibit cell growth of HCC in the Huh‐7 xenograft mouse model and the orthotopic model. RNA‐sequencing analysis revealed that inhibiting K458 acetylation enhanced the transcriptional activity of HNF4α without altering the transcriptome induced by HNF4α in HCC.

Conclusion

Our data revealed that inhibiting K458 acetylation of HNF4α might provide a more promising candidate for differential therapy of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4Carcinoma, HepatocellularLiver NeoplasmsCell DifferentiationAcetylationAnimalsHumansMiceCell Line, TumorLysineXenograft Model Antitumor Assays

Stichwörter der Autor:innen

acetylationdifferentiation therapyhepatocellular carcinomahepatocyte nuclear factor 4α

Substanzen

Hepatocyte Nuclear Factor 4HNF4A protein, humanLysine

Autor:innen und Institutionen

  • Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Wei Fen Xie

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, F., Peng, Y., Qian, H., Xiao, M. C., Ding, C. H., Zhang, X., & Xie, W. F. (2024). Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α) ‐induced differentiation therapy for hepatocellular carcinoma. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13272

Vancouver

Liu F, Peng Y, Qian H, Xiao MC, Ding CH, Zhang X, et al. Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α) ‐induced differentiation therapy for hepatocellular carcinoma. Journal of Digestive Diseases. 2024. doi:10.1111/1751-2980.13272

BibTeX
@article{Liu2024,
  author = {Liu, Fang and Peng, Yu and Qian, Hui and Xiao, Meng Chao and Ding, Chen Hong and Zhang, Xin and Xie, Wei Fen},
  title = {Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α) ‐induced differentiation therapy for hepatocellular carcinoma},
  journal = {Journal of Digestive Diseases},
  year = {2024},
  doi = {10.1111/1751-2980.13272}
}
Kostenlos starten →